Skip to main content
Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: Cost-effectiveness of the recommended medical intervention for the treatment of dysmenorrhea and endometriosis in Japan

Fig. 2

Model calibration and validation through comparison with realistic statistics. The simulation demonstrated the validity of the model in computing prevalence of approximately 210,000 cases with endometriosis, similar to that reported in a national survey (approx. 247,000a; Terakawa et al. [15]); however, a discrepancy in prevalence for age-groups of 35 years or more existed. anumber of patients with endometriosis plus adenomyosis

Back to article page